Clinical trial
TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related…
NCT00464347 · National Eye Institute (NEI), NIH · Terminated
Key facts
| NCT number | NCT00464347 |
|---|---|
| Title | TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration |
| Official title | Multi-Center, Randomized, Phase II Clinical Trial to Study the Effects of Preservative-Free Triamcinolone Acetonide and Avastin® in Combination With Photodynamic Therapy in Participants With Neovascular Age Related Macular Degeneration |
| Acronym | VERTACL |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Collaborators | QLT Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration |
| Intervention type | Drug, Procedure |
| Interventions | Avastin, Photodynamic Therapy (PDT), Preservative-Free Triamcinolone Acetonide (TAC-PF) |
| Enrollment | 100 |
| Start date | Jan 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 23, 2007 |
| Last update posted | Mar 24, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: